SPECIALITY EUROPEAN PHARMA Trademark

Trademark Overview


On Friday, December 7, 2007, a trademark application was filed for SPECIALITY EUROPEAN PHARMA with the United States Patent and Trademark Office. The USPTO has given the SPECIALITY EUROPEAN PHARMA trademark a serial number of 79048077. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, December 7, 2017. This trademark is owned by Speciality European Pharma Limited. The SPECIALITY EUROPEAN PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, neurological, dermatological, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory disorders, immune system disorders including autoimmune diseases, metabolic disorders, psychiatric disorders, allergic reactions, infectious diseases, occular disorders, multiple sclerosis, amyotrophic lateral sclerosis (ALS), Huntingdon's disease, spinal muscular atrophy, adenomatous polyposis coli, reproductive disorders, endocrinology disease, urological disorders, respiratory disorders, asthma, allergies, cancers, infectious organisms, bacterial infections, drug resistance, bacterial drug resistance, metabolic disorders, inflammation, cardiovascular diseases, viral infections, gene the...
speciality european pharma

General Information


Serial Number79048077
Word MarkSPECIALITY EUROPEAN PHARMA
Filing DateFriday, December 7, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, December 7, 2017
Registration Number3537335
Registration DateTuesday, November 25, 2008
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 9, 2008

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"EUROPEAN PHARMA"
Goods and ServicesPharmaceutical preparations for use in oncology, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, neurological, dermatological, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory disorders, immune system disorders including autoimmune diseases, metabolic disorders, psychiatric disorders, allergic reactions, infectious diseases, occular disorders, multiple sclerosis, amyotrophic lateral sclerosis (ALS), Huntingdon's disease, spinal muscular atrophy, adenomatous polyposis coli, reproductive disorders, endocrinology disease, urological disorders, respiratory disorders, asthma, allergies, cancers, infectious organisms, bacterial infections, drug resistance, bacterial drug resistance, metabolic disorders, inflammation, cardiovascular diseases, viral infections, gene therapy treatments, viral latency, genetic disorders, sickle cell anaemia, restenosis, thallasemia, bacterial infections, diabetes, central nervous system disorders and diseases, depression, schizophrenia, obesity, parasitic infections, fungal infections, skin diseases, arthritis, osteoporosis, circulatory diseases, degenerative disorders, autoimmune disease, gastrointestinal disorders and diseases, musculoskeletal disorders and diseases, renal disease, connective tissue and joint disease, eye disease
Pseudo MarkSPECIALITY EUROPEAN PHARMACEUTICAL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 26, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSpeciality European Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameSpeciality European Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameSpeciality European Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, June 29, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, June 29, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, March 31, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Friday, April 22, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, April 22, 2016INVALIDATION PROCESSED
Friday, February 26, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, September 10, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 26, 2015CANCELLED SECTION 71
Monday, January 7, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, November 30, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 18, 2009FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 18, 2009FINAL DISPOSITION PROCESSED
Thursday, February 26, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 25, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, September 9, 2008PUBLISHED FOR OPPOSITION
Wednesday, August 20, 2008NOTICE OF PUBLICATION
Tuesday, August 5, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 4, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 4, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 5, 2008ASSIGNED TO LIE
Thursday, July 31, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 6, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 6, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 6, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 6, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 19, 2008REFUSAL PROCESSED BY IB
Wednesday, March 26, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 26, 2008REFUSAL PROCESSED BY MPU
Wednesday, March 26, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 25, 2008NON-FINAL ACTION WRITTEN
Tuesday, March 18, 2008ASSIGNED TO EXAMINER
Friday, February 1, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, January 31, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB